Claire M. Steppan
Pfizer (United States)(US)PRX Research
Publications by Year
Research Areas
SARS-CoV-2 and COVID-19 Research, Adipose Tissue and Metabolism, Adipokines, Inflammation, and Metabolic Diseases, COVID-19 Clinical Research Studies, Computational Drug Discovery Methods
Most-Cited Works
- → The hormone resistin links obesity to diabetes(2001)4,738 cited
- → An oral SARS-CoV-2 M pro inhibitor clinical candidate for the treatment of COVID-19(2021)1,855 cited
- → Regulation of Fasted Blood Glucose by Resistin(2004)718 cited
- → A family of tissue-specific resistin-like molecules(2001)644 cited
- → Discovery of Ketone-Based Covalent Inhibitors of Coronavirus 3CL Proteases for the Potential Therapeutic Treatment of COVID-19(2020)523 cited
- → Resistin and obesity-associated insulin resistance(2002)521 cited
- → Leptin is a potent stimulator of bone growth in ob/ob mice(2000)517 cited
- → A futile metabolic cycle activated in adipocytes by antidiabetic agents(2002)424 cited
- → The current biology of resistin(2004)372 cited
- → Preclinical characterization of an intravenous coronavirus 3CL protease inhibitor for the potential treatment of COVID19(2021)288 cited